Overview
- 15 inspections across 15 sites are on record.
- 9 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-06-21.
At a glance
Inspections
15
Sites
15
Observations
9
Career since
Oct 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Octapharma Plasma Inc | 21 Jun 2024 | Biologics | |
| BioLife Plasma Services LP | 23 May 2024 | Biologics | |
| BioLife Plasma Services LP | 17 May 2024 | Biologics | |
| Tissue Transplant Technology, Ltd. | 3 May 2024 | Biologics | View 483 → |
| Vitalant | 27 Mar 2024 | Biologics |
Sites inspected
Octapharma Plasma IncOakland, United States1 insp.
BioLife Plasma Services LPSan Marcos, United States1 insp.
BioLife Plasma Services LPVista, United States1 insp.
Tissue Transplant Technology, Ltd.San Antonio, United States1 insp.
VitalantNapa, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Shelley H Beausoleil3 shared
Gabryelle J Solverud2 shared
John A Iwen2 shared
Eric T Huebler2 shared
Emily B Camire1 shared
Maira P Brading1 shared
Celeta S Coves1 shared
Esther A Ofori1 shared
Full investigator report
Get the verbatim findings behind Michael A Blaine's 9 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site